These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17352303)

  • 21. Drug-induced systemic lupus erythematosus.
    Stratton MA
    Clin Pharm; 1985; 4(6):657-63. PubMed ID: 2866863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab-induced SLE-like syndrome involving the lung and pleura.
    Diri E; Tello W; Ratnoff WD; Nugent K
    Lupus; 2007; 16(9):764-6. PubMed ID: 17728373
    [No Abstract]   [Full Text] [Related]  

  • 23. [Terbinafine and lupus erythematosus (1st published case)].
    Ann Dermatol Venereol; 1999 May; 126(5):463. PubMed ID: 10434115
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis.
    Dang LJ; Lubel JS; Gunatheesan S; Hosking P; Su J
    Australas J Dermatol; 2014 Feb; 55(1):75-9. PubMed ID: 23651182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
    Szepietowski JC; Nilganuwong S; Wozniacka A; Kuhn A; Nyberg F; van Vollenhoven RF; Bengtsson AA; Reich A; de Vries DE; van Hartingsveldt B; Robinson DW; Gordon R; Hsu B
    Arthritis Rheum; 2013 Oct; 65(10):2661-71. PubMed ID: 23896980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levetiracetam-induced systemic lupus erythematosus.
    Jadhav P; Kulkarni T; Jadhav J; Desai S; Baviskar R
    J R Coll Physicians Edinb; 2021 Mar; 51(1):58-60. PubMed ID: 33877137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
    Benucci M; Nenci G; Cappelletti C; Manfredi M
    Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.
    Subramanian S; Yajnik V; Sands BE; Cullen G; Korzenik JR
    Inflamm Bowel Dis; 2011 Jan; 17(1):99-104. PubMed ID: 20629183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions.
    Portanova JP; Arndt RE; Tan EM; Kotzin BL
    J Immunol; 1987 Jan; 138(2):446-51. PubMed ID: 2432124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of adverse drug reactions in patients with systemic lupus erythematosus.
    Pope J; Jerome D; Fenlon D; Krizova A; Ouimet J
    J Rheumatol; 2003 Mar; 30(3):480-4. PubMed ID: 12610805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infliximab-induced systemic lupus erythematosus.
    Ali Y; Shah S
    Ann Intern Med; 2002 Oct; 137(7):625-6. PubMed ID: 12353965
    [No Abstract]   [Full Text] [Related]  

  • 32. Association between terbinafine and arthralgia, fever and urticaria: symptoms or syndrome?
    van Puijenbroek EP; Egberts AC; Meyboom RH; Leufkens HG
    Pharmacoepidemiol Drug Saf; 2001; 10(2):135-42. PubMed ID: 11499852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.
    Ramos-Casals M; Soto MJ; Cuadrado MJ; Khamashta MA
    Lupus; 2009 Aug; 18(9):767-76. PubMed ID: 19578100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-TNF-induced lupus.
    Williams EL; Gadola S; Edwards CJ
    Rheumatology (Oxford); 2009 Jul; 48(7):716-20. PubMed ID: 19416947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
    Williams VL; Cohen PR
    Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infliximab induced lupus in patients with rheumatoid arthritis.
    Elkayam O; Caspi D
    Clin Exp Rheumatol; 2004; 22(4):502-3. PubMed ID: 15301255
    [No Abstract]   [Full Text] [Related]  

  • 37. Belimumab: review of use in systemic lupus erythematosus.
    Boyce EG; Fusco BE
    Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-TNF-alpha-induced systemic lupus syndrome.
    Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
    Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced systemic lupus erythematosus in a child after 3 years of treatment with carbamazepine.
    Molina-Ruiz AM; Lasanta B; Barcia A; Pérez-Vega E; Requena L
    Australas J Dermatol; 2017 Feb; 58(1):e20-e22. PubMed ID: 26424435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab.
    Pérez-García C; Maymo J; Lisbona Pérez MP; Almirall Bernabé M; Carbonell Abelló J
    Rheumatology (Oxford); 2006 Jan; 45(1):114-6. PubMed ID: 16319096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.